Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06194747 · ClinicalTrials.gov registry record · NA

Improving Status Epilepticus Treatment Times

A NA study of Status Epilepticus, sponsored by Nationwide Children's Hospital.

Recruiting
Registry status
NA
Development phase
450
Enrollment target
1
Study location

NCT06194747 is a NA study of Status Epilepticus that is actively recruiting participants, run by Nationwide Children's Hospital. The registered enrollment target is 450 participants, below the 2,788-participant average among 10 other Status Epilepticus trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06194747, a NA study of Status Epilepticus, is actively recruiting participants, sponsored by Nationwide Children's Hospital.

RECRUITING
Registry status
NA
Development phase
450 participants
Enrollment target
1
Study location

Study Summary

This is a stepped-wedge cluster randomized effectiveness-implementation hybrid study aimed at determining the effect of dissemination of a QI bundle on the time to treatment of SE among hospitalized, non-critically ill children. The primary study endpoint is to decrease the time from the SE diagnosis to treatment with the first dose of a benzodiazepine (BZD) as measured during hospitalization, which will decrease chances of morbidity and mortality.

Conditions Studied

Interventions

  • OTHER Quality improvement bundle
  • OTHER Quality improvement bundle and local PDSA cycles with central support
  • OTHER Quality improvement bundle and local PDSA cycles without central support

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2024-02-01
Est. Completion 2027-03-31
Phase NA

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT06194747

The ClinicalTrials.gov registry entry for NCT06194747 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,788-participant average among 10 other Status Epilepticus trials with a reported enrollment target (84% lower). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Status Epilepticus appearing as the primary indexed condition, and to 3 interventions - of which Quality improvement bundle is the first listed.

NCT06194747 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06194747 about?

NCT06194747 is a clinical study titled "Improving Status Epilepticus Treatment Times". This is a stepped-wedge cluster randomized effectiveness-implementation hybrid study aimed at determining the effect of dissemination of a QI bundle on the time to treatment of SE among hospitalized, non-critically ill children. The primary study endpoint is to decrease the time from the SE diagnosi...

What is the current status of trial NCT06194747?

This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2024-02-01. Estimated completion is 2027-03-31.

What conditions does trial NCT06194747 study?

This clinical trial studies the following conditions: Status Epilepticus.

What interventions are being tested in trial NCT06194747?

The interventions under investigation include: Quality improvement bundle (OTHER), Quality improvement bundle and local PDSA cycles with central support (OTHER), Quality improvement bundle and local PDSA cycles without central support (OTHER).

Who is sponsoring clinical trial NCT06194747?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06194747 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Status Epilepticus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.